Advertisement
Research Article Free access | 10.1172/JCI113091
Find articles by Attvall, S. in: JCI | PubMed | Google Scholar
Find articles by Eriksson, B. in: JCI | PubMed | Google Scholar
Find articles by Fowelin, J. in: JCI | PubMed | Google Scholar
Find articles by von Schenck, H. in: JCI | PubMed | Google Scholar
Find articles by Lager, I. in: JCI | PubMed | Google Scholar
Find articles by Smith, U. in: JCI | PubMed | Google Scholar
Published August 1, 1987 - More info
The insulin effect following hypoglycemia was studied with the euglycemic clamp technique in seven healthy subjects. Following an initial euglycemic clamp hypoglycemia was induced and after glucose recovery a second clamp was performed. Glucose production (Ra) and utilization (Rd) were studied with [3-3H]glucose. Each subject was studied four times; during infusion of placebo, propranolol, somatostatin, and a control study where hypoglycemia was prevented. Hypoglycemia induced an insulin resistance with a lower steady state glucose infusion rate following the hypoglycemia during placebo as compared to the control study (2.5 +/- 0.5 and 4.8 +/- 1.0 mg/kg min, respectively, P less than 0.05). The insulin resistance was due to an attenuated insulin effect on both inhibition of Ra (impaired by 37%) and stimulation of Rd (impaired by 61%). The insulin-antagonistic effect was completely prevented by propranolol but only partly by somatostatin. Thus, early posthypoglycemic insulin resistance (2.5-3.5 h after hypoglycemia) is a sustained effect mainly due to beta-adrenergic stimulation.